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ABSTRACT
RAPID METHOD OF PROCESSING SPERM FOR NUCLEIC ACID EXTRACTION
IN CLINICAL RESEARCH
MAY 2014
MATTHEW K. DE GANNES, B.S., GETTYSBURG COLLEGE
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor J. Richard Pilsner
Background: Sperm contain compact nuclei, inhibiting DNA extraction using traditional
somatic cell techniques. Previous methods extracted quality sperm DNA using reducing
agents, but with lengthy lysis procedures and no means of stabilizing DNA. These
limitations hamper efficient clinical research.
Objective: We sought to optimize an efficient method of extracting high quality,
molecular weight DNA from human sperm suitable for clinical research.
Methods: Sperm from semen samples provided by three volunteers were isolated using
modified PureCeption Gradient protocol. We tested 1) proteinase K in the presence of
DNA/RNA Shield, 2) dithiothreitol (DTT) and tris(2-carboxyethyl)phosphine (TCEP) as
reducing agents, 3) QIAshredder for sperm cell homogenization, and 4) the stability of
sperm DNA by performing DNA extractions using modified Quick-gDNA MiniPrep
protocol on sperm samples immediately (baseline) or after four weeks of storage at 4OC
in DNA/RNA Shield. DNA was amplified by PCR using ALU primers and digested with
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Hinf1 restriction enzymes. Imprinted DNA methylation was assessed using
MassARRAY.
Results: Treatment with proteinase K produced similar DNA concentrations
(30.1+0.28ng/µL and 33.4+0.21ng/µL) compared to without proteinase K in DNA/RNA
Shield (28.9+0.00ng/µL and 30.9+0.85ng/µL). No sperm cells were observed after 1
minute with 25mM TCEP treatment compared to 20 minutes with 100mM DTT. Lysis
with 50mM TCEP produced greater DNA concentrations (17.2+0.50ng/µL and
21.3+0.71ng/µL) compared to 50mM DTT (12.6+0.28ng/µL and 12.3+0.35ng/µL).
QIAshredder with 50mM TCEP increased DNA concentrations (25.9+0.35ng/µL and
21.7+0.49ng/µL) compared to 50mM TCEP alone (18.6+0.99ng/µL and
12.3+0.35ng/µL). DNA concentrations at baseline (36.2+2.75 ng/µL, 32.2+1.38ng/µL,
and 44.3+3.93ng/µL) were similar to those after 4 weeks (40.0+2.98ng/µL,
37.6+1.38ng/µL, and 38.7+3.93ng/µL). DNA from both storage times was successfully
amplified by PCR using ALU primers and efficiently digested with Hinf1 restriction
enzymes. MassARRAY revealed similar percentages of methylation at baseline and
4weeks of storage for SNURF (1.43+1.02%, 1.55+0.95%), PEG10 (3.69+0.66%,
4.28+1.52%), and H19 (88.93+3.24%, 91.78+2.00%) imprinted loci.
Conclusions: We isolated high quality, molecular weight DNA from human sperm using
5 minute versus > 2 hour lysis in other methods. DNA/RNA Shield stabilized sperm
DNA over 4 weeks. Our methods may facilitate efficient clinical research essential to
investigate the role of sperm genetics and epigenetics in male reproductive health.
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CHAPTER 1
INTRODUCTION
1.1 The Importance of Sperm to Male Reproductive Health
Epidemiological data estimate that 6-8% of the United States population was
infertile between 1982-2010 [1] and male factors contributed to nearly half of these cases
[2]. Furthermore, the decline in fertility observed between 1982-2000 was accompanied
by an overall decline in human semen quality [3]. Several epidemiological and animal
studies have revealed that there are key genetic [4-8] and epigenetic [9-13] factors
essential to proper spermatogenesis and male reproductive health. An overview of the
spermatogenesis process and the importance of key genetic and epigenetic factors to this
process are discussed below.
1.2 Spermatogenesis and Sperm Biology
1.2.1 Stages of Spermatogenesis and Cell Division
In the seminiferous epithelium, germ cells form several concentric layers
penetrated by somatic cells called Sertoli cells. The Sertoli cells extend around all the
germ cells to nurture and maintain their cellular associations throughout spermatogenesis
[14]. Germ cell differentiation is precisely regulated so that the same stages of
spermatogonia, spermatocytes, round spermatids, and late spermatids are always found in
association [15]. Because the differentiation process is spatially synchronized, a given
cross section of seminiferous tubule most often has germ cells at the same stage of
spermatogenesis. The presence of regularly repeating cell associations in a given tubule
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cross section allowed Leblond and Clermont to identify 14 stages of spermatogenesis in
the rat [16] and Oakberg to identify 12 stages in the mouse [17]. The process of
spermatogenesis is summarized in Figure 1 taken from Anatomy and Physiology [18].

Figure 1: Summary of the process of spermatogenesis from primary spermatocytes to
spermatozoa. This summary was taken from Anatomy and Physiology [18].

Spermatogenesis is a precisely timed and highly organized process by which
haploid spermatozoa are produced from diploid spermatogonial stem cells. The process
begins at puberty, after which sperm are produced constantly (200 to 300 million daily)
until age 35 in humans, when sperm production begins to slowly decline [18,19]. One
cycle of spermatogenesis, from spermatogonia through mature sperm, takes
approximately 64 days with a new cycle occurring every 16 days [18]. The cycle begins
with mitosis of diploid spermatogonia on the basement membrane of seminiferous
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tubules [18]. Type A1 spermatogonia, containing dark nuclei, divide mitotically and
reproduce themselves (homonymous division), maintaining the spermatogonia population
[20]. Type A2 spermatogonia, containing pale nuclei, may divide mitotically to produce
type A3 and then A4 spermatogonia. The type A4 spermatogonium can 1) form another
A4 spermatogonium (self-renewal), 2) undergo cell death (apoptosis), or 3) differentiate
into an intermediate spermatogonium (heteronymous division) which is inducted into
spermatogenesis. Intermediate spermatogonia divide once mitotically to form type B
spermatogonia that also divide mitotically into primary spermatocytes. It is not known
what causes the spermatogonia to take the path toward spermatogenesis rather than selfrenewal [21].
Mitosis is followed by the first meiotic division where DNA is replicated and the
chromosome number is halved in the primary spermatocyte [18]. Chromosome pairs
undergo homologous recombination involving the formation of synaptonemal complexes
in which double strand breaks occur [22]. Genetic material is then exchanged between
maternal and paternal chromosomes during repair of the breaks. At the end of the first
meiotic division, two secondary spermatocytes with identical chromosomes are produced
[18]. The second meiotic division involves the separation of individual chromatid strands
to produce four haploid, spherical cells called spermatids [18].
Following meiosis, the differentiation of spermatids occurs through a process
called spermiogenesis. This occurs in 4 phases: Golgi, capping, acrosomal, and
maturation [14]. The Golgi apparatus of these early spermatids produce vesicles and
granules containing enzymes that will cover the developing sperm nucleus. A single large
acrosomal granule within a larger vesicle indents the nucleus and the vesicle begins to
3

flatten into a small cap over the nuclear surface. The acrosomic vesicle becomes very
thin, the granule flattens, and the new acrosome flattens over the nuclear surface of the
elongating spermatid. The nuclei also begin to change shape as condensation of
chromatin and replacement of histones with protamines occurs, and the nucleus becomes
more compact [23].
The maturation phase has fewer changes in nuclear shape and acrosomal
migration, but the nucleus continues to condense. The acrosome matures into a thin
structure that protrudes at the apex, covering nearly all of the nucleus except for the
portion connected to the tail [14]. The cytoplasm is reduced, resulting in the formation of
cytoplasmic lobes and residual bodes which contain unused mitochondria, ribosomes,
lipids, vesicles, and other components [14]. The end result of this process occurs in the
final stage of spermatogenesis, in the portion of the tubule nearest the lumen, where
spermatozoa are formed [18]. The spermatozoa are released into the lumen and then
migrate through a series of ducts toward the epididymis where they mature further and
slowly acquire the ability to move on their own. The motility of sperm is dependent on
ATP produced by tightly packed mitochondria that fill the mid-piece of the sperm. The
ATP powers the flagellum, which extends from the neck through the tail of the sperm,
enabling the sperm to move [18]. The structure of a fully mature sperm is illustrated in
Figure 2 taken from Anatomy and Physiology [18].
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Figure 2: The structure of a fully mature sperm. Each sperm cell is divided into a head
containing DNA, mid-piece containing mitochondria, and tail providing motility. This diagram
was taken from Anatomy and Physiology [18].

1.2.2 Histone Replacement with Protamines
The sperm cell has a specialized architecture which allows it to traverse the
potentially hostile environment of the female reproductive tract and fertilize the human
egg [24]. Dramatic changes to sperm chromatin structure occur during spermiogenesis,
whereby 90-95% of histones are replaced with protamines [25]. Protamination of sperm
chromatin allows the nuclear compaction necessary for sperm motility and helps to
protect the genome from oxidation and harmful molecules within the female reproductive
tract [25]. Furthermore, because the higher order packaging of DNA after protamination
precludes transcriptional activity, protamination is a nontraditional form of epigenetic
regulation unique to sperm cells [23].
The replacement of histones with protamines is a multistep process and is
summarized in Figure 3 taken from Carrell et al. [26]. First, there is an increase in sitespecific acetylation, methylation, phosphorylation, and ubiquitnation of histones which
facilitate their replacement by testis-specific histones (H-t) that are expressed during
spermatogenesis [26,27]. The hyperacetylation of H4-t is a key factor that produces a
relaxed chromatin structure important for facilitating topoisomerase-induced double5

stand breaks and replacement of histones with transition proteins [28,29]. Transition
proteins 1 and 2 (TP1 and TP2) are proteins of intermediate basicity that bind to DNA,
allowing removal of histones and subsequent protamine compaction [30].

Figure 3: Diagram highlighting the key events in the transition of histones to replacement
by protamines. Histones undergo site-specific acetylation, methylation, phosphorylation and
ubiquitination which facilitate their replacement by testis-specific histones (H-t) during meiosis.
Hyperacetylation of H4-t is a key factor that produces a relaxed chromatin structure important for
facilitating topoisomerase-induced double-stand breaks and replacement of histones with
transition proteins. Protamines 1 and 2, processed from a pool of RNP particles, undergo
maturation before and during binding to the DNA and replacement of the transition proteins.
Legend: HR6B, ubiquitin-conjugating enzyme E2B (UBE2B) (RAD6 homolog); HAT, histone
acetyltransferase; Suv39, H3 Lys 9 histone methyltransferase. This diagram was taken from
Carrell et al. [26].
6

In the next step, transition proteins are completely replaced by protamines.
Protamines 1 and 2 (P1 and P2) are processed from a pool of ribonucleoprotein (RNP)
particles and undergo maturation before and during binding to the DNA and replacement
of transition proteins [26]. In healthy, fertile individuals, P1 and P2 are expressed in
roughly equal quantities [31]. Efficient chromatin packaging and compaction of the
sperm nucleus is dependent upon proper protamine replacement. The formation of
disulfide bonds between the protamines and the formation of toroidal chromatin
structures facilitates nuclear compaction [32]. Because this compaction renders the sperm
nucleus resistant to damage from harmful molecules, high quality nucleic acids cannot be
extracted from sperm using traditional somatic cell techniques [33].
Despite the replacement of histones with protamines, 5-10% of DNA in fertile
men, and more in infertile men, remain bound to histones [34,35]. Ward has proposed a
model illustrating the structural arrangement of histone- and protamine bound regions of
DNA in mature sperm in which histones are interspersed between protamine toroids and
may be bound to matrix attachment regions associated with linker regions [36,37]. The
model shows the protection of protamine-bound DNA from damage by toroidal
compaction, and the vulnerability of histone-bound and linker regions to DNA
degradation by endonucleases [38]. This model has important implications in studies
where the proper functioning of sperm and associated male fertility can be investigated
through proper replacement of histones with protamines [39,40].
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1.3 Spermatogenesis and Genetics
In mammals, many more germline cell divisions occur in the life of a sperm
compared to an egg because sperm are produced continuously throughout adult life,
unlike eggs where all cell divisions are completed before birth [4]. As the human male
ages, the number of cell divisions and chromosome replications increases, rendering the
sperm susceptible to increased de novo mutations [4,5]. Double strand breaks and DNA
repair during spermatogenesis is important for the genomic integrity of future haploid
sperm. One study showed that the loss of the nuclear protein PTIP, implicated in the
DNA damage response, in male mice resulted in cessation of spermatogenesis, testicular
atrophy, and a near complete lack of spermatozoa [22]. It has been proposed that the
increased de novo mutations may be the result of reduced fidelity of DNA replication and
efficiency of DNA repair mechanisms, which normally decline with age [41].
Epidemiological studies suggest associations of de novo mutation rates in the
male germline with paternal age that increase the risk for disease in offspring, including
achondroplasia, Apert syndrome, schizophrenia, and autism spectrum disorders [4-8].
One study estimated the odds ratio (OR) comparing non-synonymous to silent mutations
in affected autistic individuals (probands) and their unaffected siblings across 200
families [6]. The total number of non-synonymous de novo single nucleotide variants
(SNVs) was significantly greater in probands compared to unaffected siblings. Probands
also had double the odds of having non-synonymous mutations versus silent mutations
compared to unaffected siblings (OR = 1.93). The rate of these de novo SNVs was found
to increase with paternal age [6].
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These findings highlight the importance of sperm genetics to future health and
development, and underscore the importance of stable and efficient methods for the
isolation of sperm DNA.
1.4 Spermatogenesis and Epigenetics
Whereas an organism’s genotype is relatively static throughout life, the
epigenome is highly dynamic. Epigenetic alteration is defined as any heritable change in
gene expression potential without a change in DNA sequence [42]. These alterations
occur in response to the internal and external environment, and include DNA
methylation, non-coding RNA, and histone modifications. Because of its role in the
regulation of gene expression, it is critical to development and disease. The epigenome is
reprogrammed in the gametes and embryo from generation to generation, allowing for
totipotency and preventing the transmission of epigenetic error [43]. However, because
not all regions of the epigenome are reprogrammed, the transmission of epigenetic
information from parents to offspring may occur [9]. Therefore, epigenetic information
passed on by gametes may provide information on parental environmental exposures. To
date, the mechanisms underlying epigenetic inheritance are largely unknown, and there is
a lack of evidence to support epigenetic transmission via the sperm.
DNA methylation is the most characterized epigenetic modification and, in
mammals, occurs almost exclusively at the 5-position of cytosine residues within CpG
dinucleotides [44]. DNA methylation is catalyzed by DNA methyltransferases and
coordinates with other epigenetic modifications to suppress gene expression [45]. Briefly,
methyl-CpG-binding protein 2 binds methylated CpGs and recruits chromatin-remodeling
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complexes and histone deacetylases [46]. This leads to chromatin condensation which
results in limited accessibility of the transcriptional machinery to promoter regions,
suppressing gene expression.
DNA methylation is essential for allele-specific imprinting, a non-Mendelian
“parent-of-origin” form of mono-allelic inheritance. For an imprinted gene, either the
paternal (if the gene is maternally-expressed) or maternal (if the gene is paternallyexpressed) allele is heavily methylated (imprinted). Imprinting differs from bi-allelic
expression, the traditional, Mendelian form of inheritance where both parental alleles are
equally expressed for a given gene. For imprinted genes present in somatic cells, about
50% methylation is expected because only one of the alleles is imprinted. For gametes,
however, only one allele is present per gene after meiosis, therefore either complete
(100%) or no (0%) methylation is expected, depending on whether the gamete is male or
female. Therefore, for human sperm, complete and no methylation would be expected for
maternally-expressed and paternally-expressed imprinted genes, respectively.
In primordial germ cells, during gonadal sex determination, parental methylation
marks are reset and subsequently re-established in a sex-specific manner during
gametogenesis, where haploidization occurs [43]. Methylation marks in imprinted genes
and repeat regions are then maintained through fertilization into adulthood and other
marks undergo de-methylation. This process of epigenetic erasure and subsequent
reprogramming is essential for sperm maturation and represents a critical window of
susceptibility during which environmental agents may adversely influence epigenetic
regulation [9].
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Previous studies of DNA methylation in sperm revealed unique patterns compared
with somatic cells [34,47,48]. Overall, the sperm genome has been shown to be
hypomethylated compared to differentiated somatic cells, particularly at histone-enriched
promoters of developmental genes involved in spermatogenesis, cell cycle, cell
metabolism, and embryogenesis. These patterns are necessary to package and poise the
sperm genome for spermatogenesis and future embryonic development [35]. If these
patterns and imprinting of genes are disturbed during spermatogenesis, gene expression
essential for proper development may be compromised in the resulting offspring [49].
Alterations in the sperm epigenome have also been associated with male fertility issues
such as low sperm count, motility, and morphology [9-11] as well as overall male
infertility [12,13].
1.5 Summary
Previous literature has indicated that sperm possess key biomarkers for proper
spermatogenesis as well as successful embryonic development after fertilization. In
particular, assessments of developmental players during spermatogenesis from both a
genetics and epigenetics standpoint, through polymorphisms and mutations as well as
DNA methylation, may be utilized as clinical markers of male reproductive health.
However, nuclear compaction due to the replacement of histones with protamines
precludes the extraction of high quality DNA using traditional somatic cell techniques.
Therefore, the need for an efficient DNA extraction protocol for human sperm suitable
for clinical research is required.
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CHAPTER 2
LITERATURE REVIEW OF DNA EXTRACTION METHODS
A wide array of techniques exists to isolate high quality and molecular weight
DNA from mammalian somatic cells. However, these techniques are ineffective for
mammalian sperm [50,51]. This is because unlike in somatic cells, in sperm cells nearly
all histones are replaced by protamines held together by disulfide bonds, compacting the
sperm nucleus and thus rendering it resistant to conventional lysis procedures [38].
2.1 Sperm DNA Extraction
The development of efficient methods for isolating DNA from mammalian sperm
has been a gradual process. Bahnak et al. reported a protocol using guanidine thiocyanate
in a lysis buffer made with sodium citrate, sodium lauroyl sarcosinate (Sarkosyl), and βmercaptoethanol (reducing agent) to isolate high quality mammalian sperm DNA[50].
The DNA extracted was then successfully visualized during Southern blot analysis.
However, the procedure was tedious, requiring lengthy steps such as CsCl
ultracentrifugation for 20 hours and dialyzing the banded DNA for 24 hours against TrisHCl and ethylenediaminetetraacetic acid (EDTA).
The inclusion of proteinase K in subsequent methods to enhance the activity of
chaotropic agents such as guanidine thiocyanate by digesting nucleoproteins eliminated
the need for lengthy ultracentrifugation and dialyzing steps. In a method developed by
Pacheco et al. [52], sperm pellets were lysed for 16 hours in a solution containing TrisHCl, dithiothreitol (DTT; another commonly used reducing agent), sodium chloride,
EDTA, sodium dodecyl sulfate (SDS), proteinase K, and β-mercaptoethanol. DNA was
12

then extracted using a phenol/chloroform protocol, and DNA was ethanol precipitated.
While the authors were able to extract DNA used for subsequent DNA methylation
analyses, the method still required at least an overnight incubation. The method also
employed the use of harmful organic solvents (phenol and chloroform) that are
undesirable for simple laboratory procedures.
The method developed by Hossain et al.[53] was one of the first to eliminate
overnight procedures from the sperm DNA extraction protocol. Hossain et al. modified
the original protocol by Bahnak et al. for the preparation of human sperm DNA by
including proteinase K in the lysis buffer (containing guanidinium thiocyanate) to digest
nucleoproteins, and isopropanol to precipitate DNA. This modification eliminated the
need to mechanically homogenize the cells, use organic solvents for extraction, and use
ultracentrifugation for DNA precipitation. Therefore, the degradation of DNA through
mechanical homogenization and organic solvents was minimized, and the overall
procedure could be performed in ordinary laboratory facilities in a reduced amount of
time (only an incubation period of 3 hours for lysis was required). However, incomplete
protein digestion and removal of chaotropic salts persisted, limiting the quality of the
DNA yield [33].
2.1.1 Griffin’s DNA Extraction Method
A recent method by Griffin is worth highlighting because modifications were
made to Hossain’s protocol to increase the quality and yield of mammalian sperm DNA
by eliminating incomplete protein digestion and removal of chaotropic salts that may
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coprecipitate with DNA [33]. Descriptions of the lysis and extraction components as well
as the steps of and modifications to Hossain’s protocol were provided in detail [33].
Guanidine thiocyanate is one variety of chaotropic agent employed during DNA
extractions. Its functions include 1) disruption of the hydrate shell of DNA, rendering it
insoluble in aqueous solutions, 2) irreversible inactivation of RNases and DNases, 3)
disruption of the hydrophobic structures of proteins, metabolites, and other contaminants
so that they become soluble in aqueous solutions, and 4) disintegration of cellular
membranes. Guanidine thiocyanate enhances the activity of proteinase K, an enzyme that
aids in protein solubilization and lysis. Creating hydrophobic and hydrophilic
environments for DNA and proteins respectively is necessary to 1) help bind the DNA to
the hydrophobic silica membrane of spin columns in commercial extraction kits and 2)
remove proteins and other contaminants during subsequent washing steps.
The replacement of histones with protamines, which are held together by disulfide
bonds, compacts the sperm nucleus and renders it resistant to DNA extraction by
traditional somatic cell methods. Therefore, the use of reducing agents to dissociate
protamines from DNA using strong reducing agents is required. DTT and βmercaptoethanol are examples of such reducing agents which cleave disulfide bonds and
allow proteins to unfold [33]. Griffin employed DTT in the lysis buffer because it is more
effective and less toxic, works more efficiently, and has a milder odor compared to βmercaptoethanol. Furthermore, even though SDS has previously been used in DNA
extractions, it has a very low solubility in high-salt chaotropic solutions. Griffin
employed Sarkosyl in the lysis buffer because it is soluble in high-salt chaotropic
solutions and, like SDS, is used to denature proteins and disrupt cellular membranes [33].
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Overall, lysis was completed within 2 hours, whereas 3 hours was used in Hossain’s
protocol. After lysis, the addition of isopropanol allowed precipitation of DNA, and two
subsequent washes with alcohol and sodium citrate removed any chaotropic salts into
solution.
The extraction method resulted in high quality, high molecular weight genomic
DNA, with a yield of approximately 80%, an A260/280 ratio ranging between 1.8 and
2.0, and an A260/230 ratio of 2.0 and greater (as expected for pure DNA) [33]. The DNA
was also efficiently digested with restriction enzymes and amplified by PCR [33].
Despite these desirable results, a few issues do not make Griffin’s sperm DNA
extraction protocol ideal for clinical research: 1) The lack of a protocol to stabilize DNA,
2) The lengthy period taken for lysis (2 hours), 3) The unpleasant sulfur odor of DTT
[54] and 4) DTT becomes unstable in solution and must be prepared fresh for every
extraction [54]. The lack of a means to prevent the degradation of DNA yield and quality
may potentially increase the cost of clinical research because degraded sperm DNA
would need to be constantly replaced with new samples obtained from volunteers. In
addition, the lengthy period for lysis coupled with the need to prepare fresh DTT for each
sperm DNA extraction would make Griffin’s methods inefficient for studies requiring
large sample sizes. Therefore, Griffin’s methods may only be suitable for applications
where few patients or volunteers are required to be tested over a short period such as in
fertility clinics. Because clinical research typically involves large sample sizes over
potentially large time periods, a more efficient method is required where large numbers
of sperm samples can be collected and stored for long durations until DNA extraction and
analysis begins.
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2.2 Summary
Table 1 presents a summary of the methods developed for extracting sperm DNA.
The most recent method by Griffin for DNA extraction provides a promising approach
for consistently attaining high-quality yields of DNA [33,55]. Furthermore, this approach
has been validated by quality control methods that demonstrate 1) the ability to visualize
sperm genomic DNA on an agarose gel, 2) the ability to perform restriction enzyme
analysis, and 3) amplification of target regions using qPCR, However, the methods
involve a lengthy lysis procedure (2 hours) and lack a suitable storage procedure for
maintaining stable yields of DNA. These limitations may hamper efficient clinical
research for investigating male reproductive health. In addition, even though several
studies have been able to obtain DNA for downstream epigenetic profiling
[9,34,35,39,56], none have incorporated the recent methods by Griffin.
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Table 1: Summary of the development of methods for the extraction of DNA from human
sperm.
Author, year Lysis Buffer

Reducing Agent

Procedure Time

Advantages

Bahnak et
al., 1988

Guanidine thiocyanate, β-mercaptoethanol
β-mercaptoethanol,
Sarkosyl, sodium citrate

20+ hours
One of the first to
ultracentrifugation isolate high quality
and dialysis.
sperm DNA.

Hossain et
al., 1997

Guanidine thiocyanate, β-mercaptoethanol
β-mercaptoethanol,
Sarkosyl, sodium citrate
and Proteinase K

3 hours

Pacheco et
al., 2011

Tris, DTT, sodium
chloride, EDTA, SDS,
proteinase K, βmercaptoethanol

16 hours

DTT and βmercaptoethanol

Griffin, 2013 Guanidine thiocyanate, DTT
DTT, Sarkosyl, sodium
chloride, and
Proteinase K

2 hours

Disadvantages

Lengthy
ultracentrifugation (20
hrs) and dialyzing
steps (24 hrs).
Incomplete protein
Eliminated need for
digestion and removal
mechanical
homogenization, use of of chaotropic salts.
organic solvents, and
ultracentrifugation;
could be performed in
ordinary laboratories;
Lysis was completed in 3
hours.
A lengthy overnight
Lysis could be
incubation is required;
performed at room
Use of harmful organic
temperature in ordinary
solvents (chloroform)
laboratory facilities.
required.
Eliminated incomplete Lack methods to
protein digestion and
stabilize sperm DNA;
removal of chaotropic lysis time not ideal for
salts. Lysis completed in clinical research.
2 hours.

For the present study, we have optimized a rapid, simple method of extracting
high quality, high molecular weight genomic DNA from human sperm. Because we were
able to stabilize sperm DNA for 4 weeks and reduce the duration of lysis procedures to
five minutes at room temperature, our methods may be preferred to existing approaches
for clinical research where procedure time and viable sample storage duration are
important criteria. In addition, we have performed several downstream quality control
procedures: 1) PCR amplification of genomic DNA using ALU primers, 2) Hinf1
restriction enzyme digestion and analysis, and 3) DNA methylation analysis using
selected maternally and paternally imprinted genes.
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CHAPTER 3
METHODS
3.1 Sperm Cell Isolation
To isolate and purify sperm cells and prepare them for DNA extraction, fresh
semen samples were collected from three healthy volunteers (n=3) who were required to
have a period of at least 48 hours of abstinence. Sperm cells were then isolated using a
modified Continuous One-Step PureCeption Gradient (SAGE Form #81804) protocol.
The process of isolating human sperm is summarized in Figure 4. This study was
approved by the Institutional Review Board of the University of Massachusetts.

Figure 4: Summary flow diagram illustrating the steps of sperm cell isolation, purification,
and storage for DNA extraction.
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First, PureCeption 100% Isotonic Solution (SAGE Ref #ART-2100) and Quinn’s
Sperm Washing Medium (SAGE Ref #ART-1006) were brought to 37OC. A 90%
PureCeption solution was made by adding 1 volume of Quinn’s Sperm Washing Medium
to 9 volumes of PureCeption 100% Isotonic Solution. In a conical centrifuge tube, 1.52.0mL of fresh liquefied semen was gently layered on top of 1.0mL of the prepared 90%
PureCeption. If the semen volume was greater than 2.0mL, more than one tube of 90%
PureCeption was used. The tube was then centrifuged for 30 minutes at 500 x g. The 90%
PureCeption and seminal fluid were carefully removed without disturbing the sperm
pellet, leaving a small amount of 90% PureCeption over the sperm pellet.
After transferring the sperm pellet in residual 90% PureCeption solution to a clean
conical centrifuge tube, the pellet was resuspended in 4mL of Quinn’s Sperm Washing
Medium. The tube was then centrifuged at 500 x g for five minutes to wash away residual
90% PureCeption. One mL of washed sample was transferred to a new 1.5mL
microcentrifuge tube of which 20µL of the washed sample was transferred to a 0.6mL
microcentrifuge tube for cell counting. The 20µL cell counting aliquot was immediately
stored at -30OC. The sample was centrifuged for 1 minute at maximum speed and the
supernatant was removed from the sperm pellet. The sperm pellet was stored in an
appropriate volume (see methods below) of DNA/RNA Shield (Zymo Research Cat #
R1100-1-50) and was then lysed and homogenized for future DNA extractions (see
“Sperm Lysis and Homogenization” and “DNA Extraction” methods below). If the sperm
sample in DNA/RNA Shield was not used immediately, it was stored at 4OC.

19

3.2 Testing the Utility of Proteinase K Treatment
DNA/RNA Shield contains a high concentration of chaotropic guanidine
thiocyanate such that all nucleoproteins may dissolve in solution. If all nucleoproteins
dissolve in solution, the need for proteinase K to digest these proteins may be eliminated.
We therefore tested the hypothesis that the addition of proteinase K in lysis steps
involving DNA/RNA Shield has no discernable effect on sperm DNA concentrations.
After removing the supernatant from the 1mL washed sample, the sperm pellet was
resuspended in 300µL of DNA/RNA Shield. Two separate mixtures made up to a total
volume of 300µL were made with and without 25mg/mL proteinase K (Promega Part #
9PIV302) to make a 1:1 dilution of DNA/RNA Shield with nuclease-free water as
follows: 1) Mix with proteinase K (150µL sperm cells in DNA/RNA Shield, 144µL of
nuclease-free water, 3µL (0.01M) of 1M DTT (Promega, Cat # V3151), 3µL (75µg) of
proteinase K) or 2) Mix without proteinase K (150µL of sperm cells in DNA/RNA
Shield, 147µL of nuclease-free water, 3µL (0.01M) of DTT). The mixtures were
incubated for 1 hour at 56OC and a modified protocol from the Quick-gDNA MiniPrep
Kit (Zymo Research Cat # D3025) was used to extract the sperm DNA, starting with the
addition of Genomic Lysis Buffer from the extraction kit in a 3:1 ratio (see “DNA
Extraction” method below). DNA yields and quality were then determined using the
Nanodrop 2000 Spectrophotometer (Thermo Scientific, Listing # E112352).
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3.3 Comparing the Effectiveness of Different Reducing Agents
3.3.1 Sperm Cell Counting for Time-Course Experiment
Tris(2-carboxyethyl)phosphine (TCEP) has been demonstrated to be an odorless
reducing agent, more stable and more powerful than the commonly used reducing agent,
DTT [54]. Therefore, we compared the effectiveness of TCEP to DTT as reducing agents
for sperm DNA extraction using a time-course experiment. We hypothesized that
treatment of sperm cells with TCEP would result in more efficient sperm cell lysis than
DTT. Isolated sperm pellets that were stored at -20OC were treated with duplicates of
25mM Bond-Breaker TCEP Solution Neutral pH, 0.5M (Thermo Scientific Prod
#77720), and 100mM of DTT. As a negative control, we also treated sperm pellets with
200µL of DNA/RNA Shield. Sperm cells were counted at regular time intervals for a
period of 20 minutes under each counting square of a Bright-Line Hemocytometer (AO
Scientific Instruments Cat # 1483) using an inverted light microscope (Donsanto
Corporation Model TMS-F No. 210744) at 40X magnification. The mean number of cells
remaining per mL of cell suspension was calculated using the following formula:
  

      

250000
   

    
2
 
  

The value 250000/2 represents the dimensions of a single counting square and the
dilution factor represents the factor used to dilute the original cell suspension.
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3.3.2 Comparison of DNA Yields Obtained Using DTT and TCEP
We tested the hypothesis that treatment of sperm cells with TCEP would result in
greater sperm DNA concentrations than DTT. To the 1mL washed sample obtained from
sperm cell isolation, 100µL of DNA/RNA Shield and either 5µL of 1M DTT or 10µL of
500mM TCEP were added to make 50mM solutions of DTT and TCEP. The samples
were then pulse vortexed for 15 minutes using the Pulse Vortex Mixer (Fisher Scientific
Cat # 02215375) and a modified protocol from the Quick-gDNA MiniPrep Kit was used
to extract the sperm DNA, starting with the addition of Genomic Lysis Buffer from the
extraction kit in a 3:1 ratio (see “DNA Extraction” method below). DNA yields and
quality were then determined using the Nanodrop 2000 Spectrophotometer.
3.4 Testing the Utility of QIAshredder Columns for Sperm Cell Homogenization
We tested whether QIAshredder columns (Qiagen Cat # 79656), when used
together with TCEP to homogenize and lyse sperm cells, would increase DNA yield
compared to using TCEP alone. We hypothesized that QIAshredder homogenization
following sperm lysis steps would increase sperm DNA concentrations. To an isolated
sperm pellet, 360µL of DNA/RNA Shield and 40µL (50mM) of TCEP were added. The
sperm sample was then pulse vortexed for 5 minutes using the Pulse Vortex Mixer. Using
the QIAshredder kit, 200µL of the sperm sample were centrifuged for 2 minutes at
maximum speed through QIAshredder columns and collected in collecting tubes. A
modified protocol from the Quick-gDNA MiniPrep Kit was used to extract sperm DNA
from the 200µL sperm samples that did and did not undergo QIAshredder
homogenization, starting with the addition of Genomic Lysis Buffer from the extraction
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kit in a 3:1 ratio (see “DNA Extraction” method below). DNA yields and quality were
then determined using the Nanodrop 2000 Spectrophotometer.
3.5 Optimized Sperm Cell Lysis and Homogenization
After removing the supernatant from the 1mL washed sample during sperm cell
isolation, the sperm pellet was resuspended in 900µL of DNA/RNA Shield and 100µL
(50mM) of 500mM TCEP to lyse the cells. The sample was then incubated at room
temperature for 5 minutes, with occasional pulse vortexing using the Pulse Vortex Mixer.
After incubation, the sample was centrifuged in a QIAshredder column for 2 minutes at
maximum speed. If the sperm cells were not used immediately, they were stored at 4OC
for 1 month.
3.6 DNA Extraction
Guanidine thiocyanate is a chaotropic agent that removes nucleoproteins into
solution by destabilizing hydrophobic interactions and hydrogen bonds. Because
DNA/RNA Shield contains a high concentration of guanidine thiocyanate, it would be
expected to remove nucleoproteins that degrade DNA such as DNAses into solution,
stabilizing any DNA in suspended cells. Therefore, using our fully optimized sperm
isolation and DNA extraction protocol (Appendix A), we compared the stability of fresh
and 4-week-old sperm samples stored at 4OC in DNA/RNA Shield, hypothesizing that the
samples would yield similar DNA concentrations. A modified protocol from the QuickgDNA MiniPrep Kit was used to isolate and purify genomic DNA from fresh and 4week-old sperm samples. Genomic Lysis Buffer from the kit was added to the sperm
pellet suspended in DNA/RNA Shield and TCEP in a 3:1 ratio. The mixture was then
23

vortexed for 4-6 seconds and transferred to the kit’s spin column in a collection tube. The
tube was centrifuged at 10,000 x g for 1 minute and the collection tube was discarded.
After transferring the spin column to a new collection tube, 200µL of the kit’s
DNA Pre-Wash Buffer was added to the column and centrifuged at 10,000 x g for 1
minute. Two washes were then performed by adding 500µL of the kit’s g-DNA Wash
Buffer to the spin column and centrifuging at 10,000 x g for 1 minute. The spin column
was incubated at room temperature for 5 minutes and transferred to a clean
microcentrifuge tube.
To elute the DNA, 100µL of the kit’s DNA Elution Buffer was added to the spin
column. The spin column was then incubated for 3 minutes at room temperature and
centrifuged at maximum speed for 30 seconds to elute the DNA. The yield and quality of
the DNA were then determined using Nanodrop 2000 Spectrophotometer. If the DNA
was not used immediately, it was stored at 4OC for future use.
3.7 PCR and Restriction Digest of Sperm DNA
As a quality control we tested the hypothesis that fresh and 4-week-old sperm
samples would perform with equal efficacy during ALU PCR and Hinf1 digest. To
perform PCR of the isolated sperm DNA, individual 10µL PCR reactions were prepared
using 5.0µL(1X) of 2X GoTaq Hot Start Colorless Master Mix (Promega Ref # M513B),
1.0µL (0.1µM) of 1µM ALU (446bp product) forward and reverse primer mix (Integrated
DNA Technologies), 2.0µL of nuclease-free water, and 2.0µL (46ng) of genomic sperm
DNA. The PCR reaction conditions were as follows: 1) Hot start (94OC) for 2 minutes, 2)
30 cycles of denaturing (94OC), annealing (68OC), and extension (72OC), each for 30
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seconds, and 3) final extension (72OC) for 5 minutes. Supplementary Table B.1 presents
a summary of the properties of the ALU primers.
To perform restriction digests of the isolated sperm DNA, individual Hinf1
restriction digest reactions were prepared using 17.00µL (561ng) of genomic sperm
DNA, 2.0µL(1X) of 10X CutSmart buffer (New England BioLabs Cat # B7204S), and
1.0µL (100U) of 10,000U/mL Hinf1 restriction enzyme (New England BioLabs Cat #
R0155S). The restriction digests were performed by incubating the reactions at 37OC for
1 hour and then heating at 80OC for 20 minutes to inactivate the enzyme.
A 0.7% agarose gel was prepared for electrophoresis and samples were added to
wells in duplicates as follows: 3µL (69ng) genomic sperm DNA, 5µL ALU PCR product,
and 7µL (196ng) of Hinf1 digestion products. After electrophoresis was performed at
300V for 20 minutes, the gel was stained with 0.5µg/mL ethidium bromide solution for
15 minutes, destained for 15 minutes with deionized water, and visualized using the
Benchtop Variable Transilluminator (UVP Cat # M-26XV) and BioDoc-It Imaging
System (UVP Cat # M-26X).
3.8 Preparing Sperm DNA Samples for DNA Methylation Analysis
As an additional quality control, we tested the hypothesis that there would be no
discernable differences in DNA methylation between fresh and 4-week-old sperm
samples across SNURF, PEG10, and H19 imprinted loci. The protocol for preparing
genomic DNA for DNA methylation analysis using matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) is
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summarized in a scheme by van den Boom and Ehrich in Figure 5 [57]. The protocol
was performed by two different experimenters.

Figure 5: Summary scheme for preparation of bisulfite converted DNA samples for DNA
methylation analysis using matrix-assisted laser desorption/ionization time-of-flight mass
spectrometry (MALDI-TOF MS). Genomic DNA is bisulfite treated to introduce methylationdependent sequence changes and then amplified by PCR. After amplification by PCR, the PCR
product is treated with shrimp alkaline phosphatase (SAP) to remove unincorporated dNTPs that
may interfere with the subsequent cleavage reaction and methylation analyses. The reverse
strands of the PCR products are then transcribed into a single-stranded RNA. The methylation
dependent C/T changes introduced during bisulfite treatment should be represented as G/A
changes in the RNA transcript. The transcript is then cleaved base specifically by RNase A,
which cleaves at every U, and the cleavage products are analyzed by MALDI-TOF MS. Mass
signals representing methylated and non-methylated DNA build signal pairs, each representative
of the CpG site within the analyzed sequence substring. G/A changes in the RNA transcript lead
to corresponding mass signals that shift 16Da for a methylation event. If two or more CpG sites
are embedded within a cleavage product, mass signals may shift by multiples of 16Da. This
diagram was taken from van den Boom and Ehrich [57].

3.8.1 Bisulfite Treatment of Sperm DNA Samples
The EZ DNA Methylation Kit (Zymo Research) was used for bisulfite treatment
of 500ng of each genomic sperm DNA sample. Adding 100µL of M-Elution Buffer
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(Zymo Research) resulted in a mean yield of 235ng of bisulfite-converted DNA for DNA
methylation analysis. Bisulfite treatment introduces methylation dependent
cytosine/uracil (C/U) sequence changes and each uracil is subsequently converted to
thymidine (T) after PCR [57].
3.8.2 PCR Amplification of Imprinted Genes
Following bisulfite treatment, each of the three imprinted loci was amplified using
imprinted primers (Integrated DNA Technologies) for the paternally-expressed imprinted
genes PEG10 and SNURF and the maternally-expressed imprinted gene H19
(Supplementary Table B.1) through qPCR. Individual 5µL PCR reactions were
prepared using 2.5µL (1X) of 2X GoTaq Hot Start Colorless Master Mix, 1.0µL (0.2µM)
of 1µM forward and reverse primer mix (Integrated DNA Technologies), and 1.5µL
(3.5ng) of bisulfite-converted sperm DNA. The PCR reaction conditions were as follows:
1) Hot start (95OC) for 2 minutes, and 2) 40 cycles of denaturing (95OC), annealing
(58OC), and extension (72OC), each for 30 seconds.
3.8.3 Shrimp Alkaline Phosphatase (SAP) Treatment
PCR products were then treated with shrimp alkaline phosphatase (SAP;
Sequenom Item No. 10002.1) to remove unincorporated dNTPs. Keeping SAP enzyme
on ice, SAP enzyme solution was prepared for each PCR product using 1.70µL nucleasefree water and 0.30µL of SAP enzyme. After the PCR reactions were completed, 2µL of
SAP enzyme solution were added to each sample. The samples were centrifuged at 3,000
x g for 1 minute and incubated at 37OC for 20 minutes. The SAP enzyme was then
inactivated at 85OC for 5 minutes before the samples were cooled and held at 4OC.
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3.8.4 T7 Cleavage Transcription Protocol
A T Cleavage Transcription (T7) reaction was then performed to generate a
single-stranded RNA molecule from the PCR product. The RNA strand is cleaved base
specifically by RNase A after each uracil. Any C/T sequence changes introduced by
bisulfite treatment are reflected as guanidine/adenine (G/A) changes on the reverse RNA
strand, resulting in a mass difference of 16 Da for each CpG site enclosed in the cleavage
products generated from the RNA transcript [57]. Briefly, a 5µL T Cleavage
Transcription/RNase A mix was prepared for each reaction using 3.15µL of nuclease-free
water, 0.89µL of 5X T7 Polymerase buffer (Sequenom Item No. 10059), 0.24µL of T
Cleavage Transcription Mix (Sequenom Item No. 08051), 0.22µL of 100mM DTT
(Sequenom Item No. 10062), 0.44µL of T7 RNA & DNA Polymerase (Sequenom Item
No. 08050), and 0.06µL of RNase A (Sequenom Item No. 10061). After SAP reactions
were completed, the SAP treated PCR samples were centrifuged at 540 x g for 1 minute
before 2µL of T Cleavage Transcription/RNaseA mix was added to each sample. The
samples were then centrifuged at 540 x g for 1 minute before they were incubated for 3
hours at 37OC and held at 4OC overnight.
3.8.5 Conditioning with Clean Resin and MassARRAY Analysis
After the T7 cleavage transcription reaction was completed, 20µL of nuclease-free
water was added to each sample and the samples were centrifuged at 540 x g for 1
minute. To each sample, 6mg of clean resin (Sequenom Item No. 08040) were then added
to each sample. The samples were then taped to a rotator and allowed to rotate for 30
minutes. After rotation was completed, the samples were centrifuged at 3,200 x g for 5
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minutes and 10nL of each sample was dispensed onto a SpectroCHIP (Sequenom Item
No. 01509) using the MassARRAY Nanodispenser (Sequenom Model # RS1000).
Identification of methylated sites and determination of the degree of methylation for each
imprinted locus was then assessed in the cleavage products containing the imprinted
genes (PEG10, SNURF, and H19) using the MassARRAY Analyzer 4 (Sequenom Typ.
PHX-1) matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
(MALDI-TOF MS) platform. The mass signals representing nonmethylated and
methylated DNA form signal pairs, each representative of the CpG sites within the
analyzed sequence substring. The relative amount of methylated DNA for each CpG site
is then calculated from the ratio of the signal intensities for each pair [57]. The
MassARRAY platform generates quantitative methylation results for each sequencedefined analytical unit (either one individual CpG site or an aggregate of subsequent CpG
sites), each referred to as a “CpG unit.”
3.9 Statistical Analysis
Given the large error variances and imprecise estimates of measured parameters
that would be produced from the small number of participants in our study (n = 3), we
expected that the power to observe statistical differences in our results between treatment
groups would be low. Therefore, we found it inappropriate to perform tests for statistical
significance. Rather, we interpreted our results based on the consistency and magnitude
of differences between treatment groups.
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CHAPTER 4
RESULTS
4.1 Testing the Utility of Proteinase K Treatment
Figure 6 presents the comparison between lysing sperm cells in DNA/RNA
Shield with 0.01M DTT and 0.01M DTT plus 75µg proteinase K for sperm samples
obtained from two volunteers. The DNA concentration obtained after treating sperm
sample 1 with 0.01M DTT plus 75µg proteinase K (mean = 33.4+0.21ng/µL) was
marginally greater than that obtained after treatment with 0.01M DTT alone (mean =
30.9+0.85ng/µL). On the other hand, the DNA concentration obtained after treating
sperm sample 2 with 0.01M DTT plus 75µg proteinase K (mean = 28.9+0.00ng/µL) was
marginally lower than that obtained after treatment with 0.01M DTT alone
(30.1+0.28ng/µL).
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Figure 6: Comparison of sperm DNA concentrations obtained from sperm samples from
two healthy volunteers through DNA extraction after lysis in DNA/RNA Shield with either
0.01M dithiothreitol (DTT) or 0.01M DTT and 75µg proteinase K.

4.2 Testing the Effectiveness of Different Reducing Agents
4.2.1 Sperm Cell Counting for Time-Course Experiment
Figure 7 presents the mean percentage of sperm cells remaining per mL cell
suspension in DNA/RNA Shield over time after treatment with TCEP and DTT.
Treatment of sperm cells with 100mM DTT resulted in a gradual decrease in the
percentage of sperm cells/mL cell suspension observed over a period of 20 minutes, after
which no sperm cells were visible. In comparison to DTT, there was a sharper decline in
the percentage of sperm cells/mL cell suspension after treatment with 25mM TCEP over
1 minute, after which no sperm cells were visible. There was no visible decline in the
percentage of sperm cells after treatment with DNA/RNA Shield only over a period of 20
minutes.
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Figure 7: The mean percentage of sperm cells remaining per mL of cell suspension in
DNA/RNA Shield over a period of 20 minutes after treatment with 25mM tris(2carboxyethyl)phosphine (TCEP) and 100mM dithiothreitol (DTT).

4.2.2 Comparison of DNA Concentrations Obtained Using DTT and TCEP
Figure 8 presents the comparison of DNA concentrations obtained from sperm
samples from two volunteers through DNA extraction after treatment with either 50mM
DTT or TCEP reducing agents. There was an increase in the concentration of DNA
obtained from both sperm samples after treatment with 50mM TCEP compared to 50mM
DTT. Treatment with 50mM TCEP in sperm sample 1 resulted in a mean DNA
concentration of 17.2+0.50ng/µL compared to a mean DNA concentration of
12.6+0.28ng/µL after treatment with 50mM DTT. There was also an increase in the mean
DNA concentration of sperm sample 2 after treatment with 50mM TCEP
(21.3+0.71ng/µL) compared to 50mM DTT (12.3+0.35ng/µL).
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Figure 8: Comparison of sperm DNA concentrations obtained from sperm samples from
two healthy volunteers through DNA extraction after lysis with either 50mM dithiothreitol
(DTT) or tris(2-carboxyethyl)phosphine (TCEP)reducing agents.

4.3 Homogenization of Sperm Cells via QIAshredder
Figure 9 presents the comparison of sperm DNA concentrations obtained from
sperm samples from two volunteers through DNA extraction after lysis with 50mM
TCEP only or homogenization with QIAshredder columns followed by lysis with 50mM
TCEP. There was an increase in the concentration of DNA obtained from both sperm
samples after homogenizing with QIAshredder columns followed by lysis with 50mM
TCEP compared to lysis with 50mM TCEP alone. QIAshredder coupled with TCEP in
sperm sample 1 resulted in a mean DNA concentration of 25.9+0.35ng/µL compared to a
mean DNA concentration of 18.6+0.99ng/µL after lysis with 50mM TCEP only. There
was also a marked increase in the mean DNA concentration of sperm sample 2 after
coupled treatment with QIAshredder and TCEP (21.7+0.49ng/µL) compared to 50mM
TCEP only (12.3+0.35ng/µL).
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Figure 9: Comparison of sperm DNA concentrations obtained from sperm samples from
two healthy volunteers through DNA extraction after lysis with 50mM tris(2carboxyethyl)phosphine (TCEP) only or homogenization with QIAshredder followed by
lysis with 50mM TCEP.

4.4 Stability of Sperm DNA
4.4.1 Sperm DNA Concentrations and Quality
Figure 10 compares the DNA concentrations attained from baseline and 4-weekold sperm samples stored in DNA/RNA Shield at 4OC obtained from three volunteers
after performing DNA extraction procedures involving QIAshredder and 50mM TCEP.
The mean DNA concentration appeared to increase after 4 weeks of storage for sperm
samples 1 (36.2+2.75 ng/µL to 40.0+2.98ng/µL) and 3 (32.2+1.38ng/µL to
37.6+1.38ng/µL) but decrease for sperm sample 2 (44.3+3.93ng/µL to 38.7+3.93ng/µL)
although these changes were minor. Overall, the amount of time sperm samples were
stored in DNA/RNA Shield did not appear to show an effect on mean DNA
concentrations attained.
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Figure 10: Comparison of DNA concentrations attained from fresh and 4-week-old sperm
samples obtained from three healthy volunteers stored in DNA/RNA Shield after
performing DNA extraction procedures involving QIAshredder and 50mM tris(2carboxyethyl)phosphine (TCEP).

Table 2 shows the mean A260/A280 and A260/A230 ratios obtained for sperm
samples stored in DNA/RNA shield at baseline after 4 weeks. A260/A280 ratios indicate
possible contamination from proteins or phenols, and are expected to be in the range 1.81.9 for pure DNA. The mean A260/A280 ratios for fresh and 4-week-old sperm samples
ranged from 1.83 to 1.89. These ratios were similar between fresh and 4-week-old sperm
samples. A260/A230 ratios are used as secondary measures of DNA purity and indicate
possible contamination from ethylenediaminetetraacetic acid (EDTA), carbohydrates, or
phenols. These ratios are expected to range from 2.0-2.2 for pure DNA. The mean
A260/A230 ratios ranged from 0.67 to 1.76 and were also similar between fresh and 4week-old sperm samples.
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Table 2: Mean A260/A280 and A260/A230 ratios for DNA extracted from fresh and 4-weekold sperm samples obtained from three healthy volunteers. Sperm samples were suspended in
DNA/RNA Shield and 50mM tris(2-carboxyethyl)phosphine (TCEP) before being homogenized
using QIAshredder columns. Sperm DNA was then extracted from fresh and 4-week-old sperm
samples using modified protocol from the Quick-gDNA MiniPrep Kit and quantified using
Nanodrop 2000 Spectrophotometer.

Fresh
Mean
260/280
Sample (SD)
1 1.88 (0.01)
2 1.84 (0.02)
3 1.89 (0.02)

4 weeks
Mean
260/280
(SD)
1.87 (0.01)
1.87 (0.02)
1.83 (0.02)

Fresh
Mean
260/230
(SD)
1.25 (0.43)
0.67 (0.15)
1.76 (0.17)

4 weeks
Mean
260/230
(SD)
1.03 (0.61)
0.67 (0.81)
1.27 (0.21)

4.4.2 Restriction Digest and PCR of Sperm DNA
As a quality control procedure, we assessed the ability to perform downstream
genetic analyses using DNA extracted from baseline and 4-week-old samples from one of
the volunteers. Figure 11 presents a 0.7% agarose gel image of undigested genomic
sperm DNA, ALU PCR product (446bp), and restriction digests of genomic sperm DNA
using Hinf1 restriction enzyme for fresh and 4-week-old sperm DNA samples. The gel
indicates that 1) genomic sperm DNA was visualized with equal band intensity from both
fresh and 4-week-old sperm samples, indicated by the bands appearing greater than 24kb,
2) ALU PCR product size was equal to that expected (446bp) and at equal band intensity
for both fresh and 4-week-old sperm samples, and 3) equal and efficient digestion of
sperm genomic DNA by Hinf1 enzymes, indicated by the equal intensity of streaks
starting halfway down the gel.
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Figure 11: Electrophoresis of fresh and 4-week-old sperm DNA samples on 0.7% agarose
gel. Legend: Lane 1 = 24kb DNA ladder, Lane 2= 100 bp DNA ladder, Lane 3 = undigested fresh
genomic DNA, Lane 4 = undigested 4-week genomic DNA, Lane 5 = fresh ALU PCR product
(446 bp), Lane 6 = 4-week ALU PCR product (446bp), Lane 7 = fresh Hinf1 digest, Lane 8 = 4week Hinf1 digest.

4.4.3 DNA Methylation of Imprinted Genes
To evaluate the feasibility of DNA methylation analyses in sperm genomic DNA,
and to rule out DNA contamination from somatic cells, we chose three imprinted genes
for our analyses: two paternally-expressed imprinted genes (PEG10 and SNURF) and one
maternally-expressed imprinted gene (H19). Somatic cells possess two alleles, each
inherited from a different parent. Therefore, for imprinted genes, we would expect to find
a mean methylation percentage of about 50% in somatic cells. Because we were
investigating male gametes, each containing one allele for a given gene, we expected the
allele of paternally-expressed imprinted genes to be unmethylated, and the allele of
maternally-expressed imprinted genes to be fully methylated.
Bisulfite conversion of 500ng of genomic sperm DNA from the EZ DNA
Methylation Kit resulted in a mean yield of 235ng of bisulfite-converted DNA used for
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DNA methylation analysis. The degree of methylation at each CpG site for each sample
in a given imprinted gene is summarized in an epigram (Figure 12). The mean
percentage of methylation across the imprinted loci for each sample is summarized in
Table 3. As expected, there was little to no methylation in SNURF and PEG10 while
H19 was heavily methylated for each sample (Figure 12; Table 3). We also found that
the mean percentages of methylation across all CpG sites were similar between fresh and
4-week-old sperm samples for SNURF (1.43+1.02% and 1.55+0.95% respectively),
PEG10 (3.69+0.66% and 4.28+1.52% respectively), and H19 (88.93+3.24% and
91.78+2.00% respectively).
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Figure 12: The degree of methylation at each CpG site for two paternally-expressed
(SNURF and PEG10) and one maternally-expressed (H19) imprinted loci for DNA
extracted from fresh (T0) and 4-week-old (T4) human sperm samples obtained from three
healthy volunteers. Different letters (M or G) attached to the end of each sample indicate that the
sample was run by a different individual. Red circles indicate no methylation, yellow circles
indicate heavy methylation, and white circles indicate no analysis at their respective CpG sites.
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Table 3: The mean percentage of methylation occurring across paternally-expressed
imprinted loci (SNURF and PEG10) and maternally-expressed-imprinted loci (H19) for
fresh and 4-week-old sperm samples obtained from three healthy volunteers.

Mean Percentage (%)
Methylation across
SNURF Locus (SD)
Sample
Fresh
4 weeks
1
1.21 (0.30) 1.07 (0.10)
2
2.29 (1.21) 1.50 (1.11)
3
0.79 (1.11) 2.07 (1.52)
Mean 1.43 (1.02) 1.55 (0.95)

Mean Percentage (%)
Methylation across
PEG10 Locus (SD)
Fresh
4 weeks
3.94 (0.86) 3.00 (0.79)
4.06 (0.39) 3.83 (0.24)
3.06 (0.24) 6.01 (1.08)
3.69 (0.66) 4.28 (1.52)
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Mean Percentage (%)
Methylation across H19
Locus (SD)
Fresh
4 weeks
84.92 (1.89) 92.13 (2.53)
90.67 (0.47) 91.50 (3.06)
91.21 (0.41) 91.71 (1.94)
88.93 (3.24) 91.78 (2.00)

CHAPTER 5
DISCUSSION AND CONCLUSIONS
5.1 Optimization of Methods for Extraction of Human Sperm DNA
5.1.1 Sperm Homogenization and Lysis Methods
We have optimized a rapid (5 minutes of cell lysis), cost-effective protocol for
sperm cell lysis during DNA extractions. First, we eliminated the need for proteinase K
during lysis of sperm cells involving high concentrations of guanidine thiocyanate in
DNA/RNA Shield by demonstrating that there was no discernable change in DNA
concentrations obtained after lysis treatment with proteinase K and DTT compared to
DTT alone. Therefore, because proteinase K is unnecessary in the presence of high
concentrations of guanidine thiocyanate in DNA/RNA Shield for the effective lysis of
sperm cells, the costs of having to use proteinase K during DNA extractions are
eliminated. Secondly, our results also suggest that TCEP is more effective at lysing
sperm cells and results in greater yields of sperm DNA after 5 minutes of lysis at room
temperature compared to DTT. This has desirable implications for clinical research
because 1) the need for lengthy incubation steps (2 hours or more) involving heat is
eliminated and 2) TCEP is odorless and 3) TCEP is more stable at room temperature
compared to DTT [54], eliminating the need to prepare fresh aliquots of reducing agents
for each DNA extraction and improving cost-efficiency of research. Finally, we
optimized our lysis methods by demonstrating that using QIAshredder columns coupled
with TCEP for homogenizing and lysing sperm cells produced greater yields of DNA
compared to using TCEP alone.
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5.1.2 Stability of Sperm DNA after 4 Weeks of Storage
Our optimized DNA extraction protocol produced comparable yields of DNA for
fresh and 4-week-old sperm samples stored in DNA/RNA shield at 4OC. In addition, the
A260/A280 ratios for fresh and 4-week-old sperm samples were similar and in the range
between 1.8-1.9 expected for pure DNA, suggesting comparable DNA quality between
these samples. A260/A230 ratios for fresh and 4-week-old sperm samples were also
similar, but not in the expected range between 2.0-2.2 for pure DNA, suggesting the
presence of residual EDTA during extraction procedures. However, because EDTA is
used in commercial elution buffers to elute DNA used in many successful downstream
analyses, it would not be expected to affect the quality of the DNA.
Our quality control analyses also revealed equal feasibility of downstream genetic
and epigenetic analyses in fresh and 4-week-old sperm DNA samples. We found that
genetic analyses using restriction digestion and PCR may be performed equally
efficiently on sperm DNA extracted from both fresh and 4-week-old sperm samples. The
ability to perform these analyses has wide ranging applications in assessing clinical
markers of male reproductive health because reduced fidelity and efficiency of DNA
repair mechanisms during spermatogenesis, due to age or environmental factors, may
lead to harmful mutations in genes that are associated with adverse male reproductive
health outcomes [22] as well as disease and autism spectrum disorders in the next
generation [4-8].
We were also able to measure methylation in bisulfite-converted sperm DNA for
epigenetic analyses. The degree of DNA methylation was similar between fresh and 4-
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week-old sperm samples, indicating equal efficacy for DNA methylation analyses from
fresh and 4-week-old sperm samples. In addition, we found little to no methylation in the
two paternally-expressed imprinted genes (SNURF and PEG10), and heavy methylation
in the maternally-expressed imprinted gene (H19). The magnitudes of methylation for the
imprinted loci were also consistent with those found in previous literature for male
gametes [58]. Therefore, we were able to rule out any contamination from somatic cells,
where we would have expected to find approximately 50% methylation for either
maternally-expressed or paternally-expressed imprinted genes.
Erasure of imprinting and methylation marks during gonadal sex determination
and subsequent reestablishment of these marks during spermatogenesis represent critical
windows of susceptibility during which environmental agents may adversely influence
sperm epigenetic regulation [9]. A wide range of animal and epidemiological studies has
linked exposure to endocrine disrupting chemicals during these susceptibility windows to
adverse male reproductive health outcomes [59,60]. For example, exposure to phthalate
metabolites at different doses in gestating F0 generation female rats during fetal gonadal
sex determination has been shown to promote epigenetic inheritance of adverse health
outcomes in male offspring such as pubertal abnormalities, testis disease, and
obesity[10]. Analysis of the male F3 generation sperm epigenome revealed that aberrant
methylation patterns were correlated with the pathologies identified. In addition, several
epidemiological studies have linked exposure to phthalates to male infertility outcomes
such as low sperm count, motility, and morphology [61-66], as well as reduction in
fecundity specific to males [67]. Because alterations in the sperm epigenome have been
associated with adverse male reproductive health outcomes [35], DNA methylation
43

marks in sperm may provide part of the mechanistic pathway between environmental
exposures and male reproductive health and inform more targeted treatment and
intervention strategies to reduce the risk of these outcomes.
5.2 Limitations
5.2.1 Measurement Error
Variation in human measurements between sperm samples when performing
DNA extraction protocol may have reduced the accuracy of resulting sperm DNA
concentrations. However, because DNA extraction protocol was performed by the same
experimenter under controlled conditions, any variation due to human error would be
minimal.
In addition, because DNA methylation quality control preparations for PCR, SAP,
and T7 reactions were conducted by two different experimenters, human error and
variation in human measurements may have reduced the accuracy of methylation results.
However, all reaction preparations were conducted by the experimenters at the same
time, and reactions from both experimenters were run at the same time on the same
instruments, thus minimizing the potential impact of this source of error.
Measurement error can also occur due to the imprecision inherent to the DNA
methylation assays performed. However, because these assays follow a standardized
protocol, any variation occurring in fresh sperm samples would cancel out the same
variation occurring for 4-week-old samples.
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5.2.2 Small Sample Size
All sperm samples were obtained from three healthy volunteers and used for our
analyses. This small sample size may result in inaccurate estimates of differences in DNA
yields, DNA quality, and degree of DNA methylation in imprinted genes between our
fresh and 4-week-old sperm samples. This inaccuracy produces large standard errors so
that the power to detect statistical differences between fresh and 4-week-old sperm
samples would be reduced compared to larger sample sizes. Therefore, we found it
inappropriate to perform any tests for statistical significance because the results of such
tests would be virtually meaningless given our lack of statistical power. Future studies
that utilize our optimized protocol using sufficiently large sample sizes to perform
appropriate statistical tests would help to validate our results.
5.2.3 Missing DNA Methylation Data
The MassARRAY (Sequenom) MALDI-TOF platform was unable to provide
DNA methylation data for certain CpG sites in the imprinted genes we assessed. This
typically occurs if the mass of a T7 cleavage product containing one or more CpG sites is
too high or low to fall within the mass window of detection used by the MassARRAY
platform. The lack of DNA methylation data could pose problems for analysis if the
actual methylation levels for CpG sites in the undetected T7 cleavage products differ
from those that were detected, impacting our quality control assessment. However,
because only one imprinted allele is present for a given gamete, it is unlikely that the
degree of methylation would vary by the number of T7 cleavage products detected for a
given imprinted locus.
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5.3 Future Assessments of Sperm Profiles for Clinical Research
5.3.1 Importance of RNA in Sperm
A wide range of RNAs exist in mature human spermatozoa, from large messenger
RNAs (mRNAs) [68] to small noncoding RNAs (sncRNAs) [69]. Mature spermatozoa
are transcriptionally and translationally quiescent because they are devoid of intact
ribosomal RNAs (rRNAs), including 28S and 18S transcripts [70]. Failure to observe
rRNAs in sperm was previously attributed to the large reduction in cytoplasmic volume
during spermiogenesis which expelled translational machinery [71,72]. However, recent
studies using Next Generation Sequencing revealed that rRNA fragments abound,
suggesting that cleavage (not expulsion of rRNA) is responsible for preventing spurious
translation following spermiogenesis[73,74].
Until recently, the observations of RNA in mature sperm were met with
skepticism because of the view that the highly condensed sperm nucleus is
transcriptionally inactive[70] and contamination from mitochondria or cytoplasmic
residues could not be ruled out [75]. Advances in RNA extraction technologies in the late
1990s using reverse transcriptase polymerase chain reaction (RT-PCR), in situ
hybridization, and microarrays lacked any residual cytoplasm, mitochondria or somatic
contaminants during preparations, thus ruling out any possible contamination [68,76-78].
The validity of all three methods was subsequently confirmed in a single study [79].
Both mammalian and plant studies have identified many RNAs in sperm [80,81]
and these RNAs have been associated with a wide range of biological processes [68,69].
These processes continue to be subject to investigation, but provide the first clues to
46

understanding the early events of post-fertilization and development. One generally
accepted hypothesis is that paternally derived mRNAs remain translationally inactive in
mature sperm, and some mRNAs are selectively retained until delivery to the oocyte [73].
The mechanism by which this occurs is the subject of much debate, but one possibility
has been well characterized. During the final transcriptional period of spermiogenesis,
several mRNAs are produced and then sequestered for storage as inactive messenger
ribonucleoprotein particles (mRNPs) [82]. This sequestration is necessary for
preservation of intact mRNAs before the sperm is delivered to the oocyte at fertilization.
A study that compared transcripts retained in sperm from pooled and individual human
ejaculates found the existence of a common spermatozoal mRNA fingerprint [68]. The
RNA profile found included transcripts implicated in fertilization and development.
These RNAs have since been independently observed in zygotes following fertilization
[83]. The findings suggest that the RNAs retained in sperm and delivered to the oocyte at
fertilization are not solely remnants of transcription during spermatogenesis, but may be
essential for future embryonic development.
sncRNAs have also been suggested to play a role in regulating gene expression
during spermatogenesis and future embryonic development, influencing offspring
phenotype [84,85]. sncRNAs are approximately between 18 and 39 nucleotides in size
and classified according to their biogenesis [86]. In somatic cells, these molecules
function in post-transcriptional gene regulation, chromatin structure, and inhibiting
transposition [73]. Small interfering RNAs (siRNA) and miRNAs are two of the most
characterized classes of sncRNAs. Ranging in length from 20-24 nucleotides, these
molecules are processed from loops in single-stranded DNA known as hairpins in
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pathways involving the RNA-induced silencing complex (RISC) and DICER [73]. Data
pertaining to sncRNAs in mature sperm have been largely uncharacterized to date.
A recent review highlighted that although miRNAs were the first class of
sncRNAs observed in mammalian sperm, they account for only a small percentage (3%)
of known sncRNAs aligned to the sperm genome [73]. Because post-transcriptional
regulation of early embryonic development is strongly down-regulated during oocyte
maturation and not required for preimplantation development [87,88], it is possible that
paternal miRNAs and other sncRNAs delivered to the zygote bypass this regulatory
pathway altogether. In somatic cells, sncRNAs bind to complimentary promoter regions,
silencing gene transcription through the recruitment of PcG proteins and repressive
histone marks [89]. The majority of miRNAs identified in sperm originate from promoter
regions [73], suggesting that these transcripts may bind to paternal DNA during nuclear
remodeling, influencing sperm chromatin structure, before being delivered to the oocyte.
In addition to siRNAs and miRNAs, the presence of piwi-interacting RNAs
(piRNAs) has been demonstrated in spermatogenic cells [90]. Ranging in size from 26-30
nucleotides, these sncRNAs are produced independent of DICER and RISC, not requiring
double-stranded RNA folding [73]. Their function is essential to spermatogenesis
because, complementary to transposons, these RNAs repress the rate of transposition,
protecting the paternal genome from mobile elements [73]. Though assumed to be absent
from mature sperm because of their function, a restricted set of piRNAs may be retained
[73].
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The potential applications of sperm RNAs have been summarized in a review
[75]. The presence of RNAs in mature sperm indicates that the male gamete does not
only serve as a vehicle for paternal DNA to the oocyte, but also carries key molecular
markers in RNA, chromatin, and the nuclear matrix that are essential for proper
embryonic development [73]. The presence or absence of the various stage-specific
transcripts in mature sperm may provide a means to assess the fidelity of each stage of
spermatogenesis. For example, PRM transcripts have been applied in clinics as their
absence from ejaculate samples has been used to 1) confirm vasectomy and 2) diagnose
male-factor infertility [75]. Overall, all RNAs reflect the transcriptional history of
spermatogenic differentiation and their applications show great promise as a diagnostic
tools.
5.3.2 Extraction of Sperm RNA
The identification of RNA in mature spermatozoa, together with evidence linking
its function to male fertility and future embryonic development [73,75,83], necessitated
the development of reliable protocol to extract high-quality, high molecular weight RNA
for downstream applications such as microarray profiling or PCR. The heterogeneous
population of cells present in ejaculate and the small quantity of RNA present in cells
(50fg of RNA/cell and 0.3fg of sncRNA/cell[55]) has represented some of the main
challenges to the successful development of this protocol over several years[55,91,92].
Furthermore, because mature spermatozoa are transcriptionally and translationally
quiescent, rRNA markers are virtually absent, hindering quality assessment. These
challenges have necessitated 1) a purifying step to isolate only spermatozoa from a pool
of somatic cell-containing ejaculate, 2) optimization of RNA extraction protocol to
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maximize yield, and 3) the identification of new markers for sperm RNA quality
assessment.
In the most recent protocol described by Goodrich et al. [55], a guanidinium
thiocyanate-phenol-chloroform method to remove contaminating DNA was combined
with Qiagen’s column-based RNeasy Mini and Minielute kits to obtain high-quality
fractions of spermatozoal sncRNAs and mRNAs. The protocol incorporated βmercaptoethanol for cell lysis, nuclease-free stainless steel beads for homogenization
using Disruptor Genie (Scientific Industries), and RNase block (Stratagene) to inhibit
degradation from residual RNases.
Quality control was performed through Turbo DNase buffer (Ambion) treatment,
reverse transcription, and PCR amplification with intron-spanning primers to verify the
absence of genomic contamination and mRNA integrity[55]. Real-time PCR with PRM1
primers showed that DNase-treated samples were void of amplification while only human
genomic controls amplified, indicating that DNA contaminants were successfully
removed. In addition, RNA integrity was assessed through two methods. First, reversetranscription of spermatozoal RNAs and subsequent real-time PCR on the cDNA
products using PRM1 primers were performed. Products from cDNA amplification were
smaller than products from DNA amplification because the PRM1 primers chosen were
intron spanning [55]. Secondly, Bioanalyzer (Agilent) kits for total RNA and small RNA
were used to verify 1) the absence of intact 18S and 28S rRNAs and 2) the presence of
sncRNA respectively. The profiles showed that 18S and 28S rRNAs were undetectable,
confirming their degradation, as well as the presence of sncRNAs as a rise in fluorescent
units above background between 6 and 30 nucleotides in length [55].
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While the recent methods published by Goodrich et al. [55] demonstrate the
ability to yield high quality, high molecular weight RNA, these methods lack a means to
stabilize the RNA for periods suitable for clinical research. We are currently developing a
method for rapidly attaining high quality RNA from human sperm using similar
stabilizing protocol from our DNA extraction methods.
5.3.3 Sperm Histone Retention and Histone Modifications
A major subject of debate is whether selective post-meiotic retention of histones
poises specific genomic regions of the sperm for early use during embryonic
development. Initial evidence supporting this notion came from findings that showed
histones bound to DNA in a sequence-specific manner around gene regulatory regions
[93,94]. Isolation and interrogation of histone-associated sequences indicated that these
regions include imprinted regions [95], telomeres [96,97], retroposon DNA [96], and
specific gene loci [94,96,98]. In comparison to these regions, centromeric and
pericentromeric regions of mammalian sperm have been found to lack histones,
presenting a mix of histones and protamines [94].
Recent advances in genome-wide analysis techniques now allow detection of
histone-enriched regions at the primary sequence level. For example, CGH tiling arrays
have associated histone-bound DNA with gene-dense regions, developmentally regulated
promoters, and CTCF binding sites [99]. Next generation sequencing (NGS) exhibited
even higher resolution analysis, revealing enrichment of histone-associated sequences at
developmentally important genes such as spermatogenesis genes, embryonic transcription
factors, and signaling machinery, as well as microRNA (miRNA) and imprinted gene
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regions [34]. Further analyses revealed that internal exons also show significantly greater
histone enrichment than intronic sequences, and histones were found to be distributed at
relatively low levels outside of promoter regions [100]. It has also been proposed that
histone-bound DNA retained in mature sperm mark sites of nuclear matrix attachment at
scaffold/matrix attachment regions (S/MARs) anchoring decondensed DNA loops of
prior cell types [36]. These markers may serve to deliver further information on paternal
nuclear architecture to the zygote [36].
The promoters of developmental genes and certain noncoding RNAs in sperm
have been associated with H3 Lysine 4 methylation (H3K4me3), a gene-activating
histone modification, while lacking H3 Lysine 27 methylation (H3K27me3), a repressive
histone modification [34]. On the other hand, promoters of genes encoding transcription
factors important for embryonic development and morphogenesis bear two histone
modifications with antagonistic roles: H3K4me3 and H3K27me3-together known as
‘bivalent’ chromatin [34]. At these sites, large regions of H3K27me3 overlap with
smaller regions of H3K4me3, potentially poising genes for either activation or repression
later in development [101].
Overall, these findings suggest that the sperm genome may be packaged and
poised for two important processes: 1) spermatogenesis through active chromatin marks,
and 2) future embryonic development through bivalent chromatin domains. These
possibilities open new questions about whether various environmental and lifestyle
factors may influence sperm histone modifications in a manner that impacts male fertility
or future embryo development. The ability to perform sperm histone modification
analysis has been demonstrated using standard chromatin immunoprecipitation (ChIP)
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assays [34,101]. Whether our sperm stabilization methods are compatible with these
assays for clinical research warrants further study.
5.4 Conclusions
We have optimized methods to extract human sperm DNA rapidly under simple
conditions, eliminating the need for costly, inefficient alternative protocol not ideal for
clinical research. Furthermore, storing sperm samples in DNA/RNA shield at 4OC
stabilized sperm DNA mass and quality over a period of 4 weeks. This stability increases
the cost-efficiency of clinical research because it minimizes the need to produce fresh
sperm DNA samples for each downstream genetic and epigenetic application.
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APPENDIX A
HUMAN SPERM CELL ISOLATION AND DNA EXTRACTION
A.1 Materials
PureCeption 100% Isotonic Solution

SAGE Ref # ART-2100

Quinn’s Sperm Washing Medium

SAGE Ref # ART-1006

DNA/RNA Shield

Zymo Research Cat # R1100-1-50

Bond-Breaker TCEP Solution Neutral pH, 0.5M

Thermo Scientific Prod # 77720

Pulse Vortex Mixer

Fisher Scientific Cat # 02215375

QIAshredder

Qiagen Cat # 7965

Quick-gDNA MiniPrep Kit

Zymo Research Cat # D3025

A.2 Sperm Cell Isolation Protocol
1. Bring PureCeption 100% Isotonic Solution and Quinn’s Sperm Washing Medium
to 37OC before use. Make a 90% PureCeption solution by adding 1 volume of
Quinn’s Sperm Washing Medium to 9 volumes of PureCeption 100% Isotonic
Solution.

2. Add 1.0mL of 90% PureCeption to a 15mL conical centrifuge tube.

3. Gently layer 1.5-2.0mL of fresh liquefied semen on top of the 90% PureCeption
using a transfer pipette. There should be no mixing of the sample and the 90%
PureCeption. If the semen volume is more than 2.0mL, use more than one tube of
90% PureCeption.

4. Centrifuge at 500 x g for 30 minutes.

5. Using a pipette, carefully remove the 90% PureCeption and seminal fluid without
disturbing the sperm pellet, leaving a small amount of 90% PureCeption over the
sperm pellet. Aspirate from the top downward, always keeping the pipette tip just
below the fluid surface. If no sperm pellet is clearly visible, remove all but 0.5mL
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of the 90% PureCeption layer. This will allow for the collection of sperm
suspended in the 90% PureCeption. Transfer the sperm pellet in this residual
medium to a clean conical centrifuge tube for further washing.

6. Using a pipette, add 4mL of Quinn’s Sperm Washing Medium and resuspend the
pellet by gently tapping with your fingers.

7. Centrifuge the mixture at 500 x g for five minutes to wash away residual 90%
PureCeption solution.

8. Placing the pipette to the bottom of the tube, remove 1mL of washed sample and
place in a new 1.5mL microcentrifuge tube.

9. Centrifuge the tube for 1 minute at maximum speed and then carefully remove the
supernatant.

10. Resuspend the sperm pellet in 900µL of DNA/RNA shield and 100µL (50mM) of
0.5M TCEP. Mix and incubate at room temperature for 5 minutes with occasional
vortexing using the Pulse Vortex Mixer.

11. Centrifuge half the volume of mixture in a QIAshredder column twice for 2
minutes at maximum speed. If the sperm cells will not be used immediately, cells
in DNA/RNA shield can be stored at 4OC for up to a month.

A.3 Sperm DNA Isolation Protocol
1. Add Genomic Lysis Buffer from the Quick-gDNA MiniPrep Kit to the mixture in
a 3:1 ratio.

2. Transfer the mixture to a Zymo-Spin Column in a Collection Tube. Centrifuge at
10,000 x g for one minute. Discard the Collection Tube with the flow through.

3. Transfer the Zymo-Spin Column to a new Collection Tube. Add 200µL of DNA
Pre-Wash Buffer to the spin column. Centrifuge at 10,000 x g for one minute.
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4. Add 500µL of g-DNA Wash Buffer to the spin column. Centrifuge at 10,000 x g
for one minute. Repeat this step once and then incubate at room temperature for
five minutes.

5. Transfer the spin column to a clean microcentrifuge tube. Add 100µL DNA
Elution Buffer to the spin column. Incubate for 3 minutes at room temperature
and then centrifuge at maximum speed for 30 seconds to elute the DNA. If the
DNA will not be used immediately, store at 4OC.
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APPENDIX B
SUPPLEMENTARY TABLES AND FIGURES
Table B.1: Primers used to amplify ALU, SNURF, PEG10, and H19 loci by PCR from DNA
extracted from human sperm samples. ALU was amplified from non-bisulfite-converted DNA
for assessment of PCR amplification and the imprinted loci SNURF, PEG10, and H19 were
amplified from bisulfite converted DNA for DNA methylation analysis. Underlined sequences in
lowercase letters represent the T7-promoter tagged reverse primer for in vitro transcription and a
10mer-tag sequence added to the forward primer to balance the PCR primer length.
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